These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

297 related items for PubMed ID: 32004567

  • 21. No Additional Benefit of Combining Fractional Carbon Dioxide Laser With Narrow-Band Ultraviolet B Phototherapy for Vitiligo: A Randomized Prospective Study With Half-Body Side Comparison.
    Eşme P, Gür Aksoy G, Elçin G.
    Dermatol Surg; 2019 Dec; 45(12):1627-1634. PubMed ID: 30829772
    [Abstract] [Full Text] [Related]

  • 22. Tacrolimus (FK506) ointment combined with Nb-UVB could activate both hair follicle (HF) and dermal melanocyte precursors in vitiligo: the first histopathological and clinical study.
    Gauthier Y, Almasi-Nasrabadi M, Cario-André M, Pain C, Rakhshan A, Ghalamkarpour F.
    Arch Dermatol Res; 2021 Jul; 313(5):383-388. PubMed ID: 32303824
    [Abstract] [Full Text] [Related]

  • 23. Apremilast, an oral phosphodiesterase 4 inhibitor, in patients with psoriatic arthritis and current skin involvement: a phase III, randomised, controlled trial (PALACE 3).
    Edwards CJ, Blanco FJ, Crowley J, Birbara CA, Jaworski J, Aelion J, Stevens RM, Vessey A, Zhan X, Bird P.
    Ann Rheum Dis; 2016 Jun; 75(6):1065-73. PubMed ID: 26792812
    [Abstract] [Full Text] [Related]

  • 24. Triple combination therapy of narrowband ultraviolet B, fractional carbon dioxide laser and topical bimatoprost 0.01% for non-segmental vitiligo on non-facial areas: A randomized half-body, double-blind, placebo-controlled, comparative study.
    Kanokrungsee S, Khunkhet S, Rojhirunsakool S, Thadvibun K, Sahaspot T.
    Dermatol Ther; 2022 Jan; 35(1):e15198. PubMed ID: 34750933
    [Abstract] [Full Text] [Related]

  • 25. Efficacy of narrow band UVB with or without OMP in stabilization of vitiligo activity in skin photo-types (III-V): A double-blind, randomized, placebo-controlled, prospective, multicenter study.
    Esmat SM, El-Mofty M, Rasheed H, Mostafa WZ, Anbar TS, Abdallah M, Bassiouny D, Abdel-Halim D, Hegazy R, Eid AA, Nassar A, Abdel-Aziz RT, Fawzy MM, Gawdat HI, El Hawary M, Sany I, Shalaby S, Ragab N, Abdel-Gaber RM, Tawfik YM, El-Bassiouny M, El-Husseiny R, Attia MS, Farid C, Genedy RM, Mogawer RM.
    Photodermatol Photoimmunol Photomed; 2022 May; 38(3):277-287. PubMed ID: 34726808
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Comparison of efficacy and safety profile of topical calcipotriol ointment in combination with NB-UVB vs. NB-UVB alone in the treatment of vitiligo: a 24-week prospective right-left comparative clinical trial.
    Khullar G, Kanwar AJ, Singh S, Parsad D.
    J Eur Acad Dermatol Venereol; 2015 May; 29(5):925-32. PubMed ID: 25220387
    [Abstract] [Full Text] [Related]

  • 28. A comparative interventional study of narrowband ultraviolet B alone and narrowband ultraviolet B in combination with microneedling in patients with stable vitiligo.
    Kaur A, Barman KD, Sahoo B, Choudhary P.
    Photodermatol Photoimmunol Photomed; 2023 Jul; 39(4):357-363. PubMed ID: 36419200
    [Abstract] [Full Text] [Related]

  • 29. Combined treatment with fractional carbon dioxide laser, autologous platelet-rich plasma, and narrow band ultraviolet B for vitiligo in different body sites: A prospective, randomized comparative trial.
    Abdelghani R, Ahmed NA, Darwish HM.
    J Cosmet Dermatol; 2018 Jun; 17(3):365-372. PubMed ID: 28834191
    [Abstract] [Full Text] [Related]

  • 30. Tacalcitol and narrow-band phototherapy in patients with vitiligo.
    Leone G, Pacifico A, Iacovelli P, Paro Vidolin A, Picardo M.
    Clin Exp Dermatol; 2006 Mar; 31(2):200-5. PubMed ID: 16487090
    [Abstract] [Full Text] [Related]

  • 31. A comparative study of combined microneedling and narrowband ultraviolet B phototherapy versus their combination with topical latanoprost in the treatment of vitiligo.
    Neinaa YME, Lotfy SS, Ghaly NR, Doghaim NN.
    Dermatol Ther; 2021 Mar; 34(2):e14813. PubMed ID: 33497514
    [Abstract] [Full Text] [Related]

  • 32. Study the effect of erbium:YAG laser plus topical 5-flurouracil in stable vitiligo resistant to NB-UVB phototherapy.
    Doghaim NN, El-Tatawy RA, Ismail MA, Ali DAM, El Attar YA.
    J Cosmet Dermatol; 2020 Jan; 19(1):122-130. PubMed ID: 31571367
    [Abstract] [Full Text] [Related]

  • 33. Oral gliadin-protected superoxide dismutase in addition to phototherapy for treating non-segmental vitiligo: A 24-week prospective randomized placebo-controlled study.
    Fontas E, Montaudié H, Passeron T.
    J Eur Acad Dermatol Venereol; 2021 Aug; 35(8):1725-1729. PubMed ID: 33931900
    [Abstract] [Full Text] [Related]

  • 34. Apremilast, an oral phosphodiesterase 4 inhibitor, in the treatment of Japanese patients with moderate to severe plaque psoriasis: Efficacy, safety and tolerability results from a phase 2b randomized controlled trial.
    Ohtsuki M, Okubo Y, Komine M, Imafuku S, Day RM, Chen P, Petric R, Maroli A, Nemoto O.
    J Dermatol; 2017 Aug; 44(8):873-884. PubMed ID: 28391657
    [Abstract] [Full Text] [Related]

  • 35. Randomized clinical trial of combined therapy with oral α-lipoic acid and NB-UVB for nonsegmental stable vitiligo.
    Sun Y, Guan X, Wang H, Zhang J, Gu H, Lu H, Yao Z, Chen X, Zeng F, Wu Y, Gao XH.
    Dermatol Ther; 2021 Jan; 34(1):e14610. PubMed ID: 33258534
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Comparative efficacy between localized 308-nm excimer light and targeted 311-nm narrowband ultraviolet B phototherapy in vitiligo: A randomized, single-blind comparison study.
    Poolsuwan P, Churee C, Pattamadilok B.
    Photodermatol Photoimmunol Photomed; 2021 Mar; 37(2):123-130. PubMed ID: 33047405
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Apremilast and narrowband ultraviolet B combination therapy suppresses Th17 axis and promotes melanogenesis in vitiligo skin: a randomized, split-body, pilot study in skin types IV-VI.
    Kim HJ, Del Duca E, Pavel AB, Singer GK, Abittan BJ, Chima MA, Kimmel G, Bares J, Baum D, Gagliotti M, Genece J, Chu J, Lebwohl MG, Guttman-Yassky E.
    Arch Dermatol Res; 2023 Mar; 315(2):215-221. PubMed ID: 35279741
    [Abstract] [Full Text] [Related]

  • 40. Effect of narrow-band ultraviolet B on the serum of 25-hydroxyvitamin D in vitiligo patients.
    Ibrahim H, El Taieb M, El Gamel Z, El Saied AR.
    J Cosmet Dermatol; 2018 Oct; 17(5):911-916. PubMed ID: 29524288
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 15.